Integrated phase II/III clinical trials in oncology: A case study Conference

Wang, Meihua, Dignam, James J, Zhang, Qiang E et al. (2012). Integrated phase II/III clinical trials in oncology: A case study . CLINICAL TRIALS, 9(6), 741-747. 10.1177/1740774512464724

Open Access

cited authors

  • Wang, Meihua; Dignam, James J; Zhang, Qiang E; DeGroot, John F; Mehta, Minesh P; Hunsberger, Sally

sustainable development goals

authors

date/time interval

  • April 13, 2011 -

publication date

  • December 1, 2012

webpage

published in

keywords

  • BEVACIZUMAB
  • CANCER
  • DESIGNS
  • HYPOTHESES SELECTION
  • II TRIALS
  • INTERIM
  • Life Sciences & Biomedicine
  • MALIGNANT GLIOMAS
  • Medicine, Research & Experimental
  • RECURRENT
  • Research & Experimental Medicine
  • SURVIVAL
  • Science & Technology
  • TOXICITY

Location

  • Philadelphia, PA

Digital Object Identifier (DOI)

Conference

  • University-of-Pennsylvania Annual Conference on Statistical Issues in Clinical Trials

publisher

  • SAGE PUBLICATIONS LTD

start page

  • 741

end page

  • 747

volume

  • 9

issue

  • 6